PROBIOTICS IN TREATMENT OF ATOPIC DERMATITIS - TRUE OR MYTH WHAT IS THE EFFECTIVENESS OF PROBIOTICS IN REDUCING ECZEMA SYMPTOMS AND IMPROVING QUALITY OF LIFE IN CHILDREN WITH ECZEMA?

Atopic dermatitis (AD) is the most common chronic inflammatory skin disorder affecting up to 20% of children. AD is usually the first step of the atopic march, with a sequential progression to respiratory allergic diseases (asthma and allergic rhinitis). The aim of this prospective real life study was to follow up the efficacy of mixture of 3x109 CFU (colony forming unites) of 3 probiotic strains Lactobacillus Casei BL 2401, Lactobacillus Salivarius BL 2201, Bifidobacterium Breve BL 3406 in combination with 7mg Zinc in Hypro-ri form for better resorption and 1200 IJ Vitamin D3 (Imunolak Kids D3 Zn) in the group of children with atopic dermatitis. Tretament period was3 months. Children with mild to moderate AD who have received Imunolak Kids D3 Zn were followed up for the next 6 months after cessation of the probiotic supplementation for AD and respiratory tract diseases (including both upper and lower respiratory tract infection and exacerbation of asthma and/or allergic rhinitis in children with those comorbidities). Our observation showed that 6 months after cessation of the treatment AD was under control, while although during the study we noticed less respiratory tract diseases, 3 months of probiotic usage didn’t have prolonged effects.